Industry News
Nipple injections to treat breast cancer
Oct 08, 2013
Doctors in Boston, MA, are investigating the possibility of administering drugs directly into the milk ducts via the nipple to treat breast cancer. According to the American Cancer Society, breast cancer is the second most common cancer among American women after skin cancers. They estimate that 1 in 8 women will develop invasive breast cancer during their lifetimes... Read More
A better way to make antibody-guided therapies
Oct 08, 2013
Chemists at The Scripps Research Institute (TSRI) have devised a new technique for connecting drug molecules to antibodies to make advanced therapies... Read More
Myriad's myRisk Hereditary Cancer™ test improves colon cancer testing by 60 percent
Oct 08, 2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new clinical data from a study with myRisk Hereditary Cancer, a 25-gene hereditary cancer panel, that showed a 60 percent increase in mutations detected in cancer predisposition genes in patients with a prior history of colon cancer and/or polyps. Read More
Myriad's myRisk Hereditary Cancer™ test improves colon cancer testing by 60 percent
Oct 08, 2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new clinical data from a study with myRisk Hereditary Cancer, a 25-gene hereditary cancer panel, that showed a 60 percent increase in mutations detected in cancer predisposition genes in patients with a prior history of colon cancer and/or polyps... Read More
In girls from low-income families,cultural differences shed light on non-completion of HPV vaccination
Oct 08, 2013
Although they are at higher risk for cervical cancer, girls from low-income families are less likely to receive the human papillomavirus (HPV) vaccine that prevents it, and the reasons they are not fully vaccinated differ depending on whether their parents are English-speaking or Spanish-speaking, suggests research presented at IDWeek 2013™... Read More
A protein discovered that triggers inflammatory responses in hemorrhage and sepsis
Oct 08, 2013
Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine... Read More
Myriad's myRisk Hereditary Cancer™ test improves colon cancer testing by 60 percent
Oct 08, 2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new clinical data from a study with myRisk Hereditary Cancer, a 25-gene hereditary cancer panel, that showed a 60 percent increase in mutations detected in cancer predisposition genes in patients with a prior history of colon cancer and/or polyps... Read More
Little-explored regions of genome reveals dozens of potential cancer triggers
Oct 08, 2013
A massive data analysis of natural genetic variants in humans and variants in cancer tumors has implicated dozens of mutations in the development of breast and prostate cancer, a Yale-led team has found. The newly discovered mutations are in regions of DNA that do not code for proteins but instead influence activity of other genes... Read More
Program improves sun protection practices among children of melanoma survivors
Oct 08, 2013
Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention - a publication of the American Association for Cancer Research. A team of researchers led by Ellen R... Read More
Discovery of new therapeutic agents may benefit leukemia patients
Oct 08, 2013
An Indiana University cancer researcher and his colleagues have discovered new therapeutic targets and drugs that may someday benefit people with certain types of leukemia or blood cancer. Reuben Kapur, Ph.D... Read More
Previous Page Next Page